Literature DB >> 11107657

Invasive meningococcal disease in Canada, 1 January 1997 to 31 December 1998.

S G Squires1, L Pelletier, M Mungai, R Tsang, F Collins, J Stoltz.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 11107657

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


× No keyword cloud information.
  13 in total

1.  Meningococcal disease: oh no, not another childhood vaccine.

Authors:  Erica Weir
Journal:  CMAJ       Date:  2002-04-16       Impact factor: 8.262

2.  Evaluation of a rapid PCR assay for diagnosis of meningococcal meningitis.

Authors:  David C Richardson; Lisa Louie; Marie Louie; Andrew E Simor
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

3.  DNA Sequence analysis of the PorB protein of nonserotypeable serogroup C ET-15 meningococci suggests a potential mutational hot spot on their serotype antigens.

Authors:  Dennis K S Law; Averil M Henderson; Raymond S W Tsang
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

4.  Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: A decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type during the period from 2002 to 2009.

Authors:  Jianwei Zhou; Frances Jamieson; Sharon Dolman; Linda Mn Hoang; Prasad Rawte; Raymond Sw Tsang
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

Review 5.  The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine.

Authors:  Robert Welte; Caroline L Trotter; W John Edmunds; Maarten J Postma; Philippe Beutels
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

6.  Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001.

Authors:  Raymond Sw Tsang; Susan G Squires; Wendell D Zollinger; Fraser E Ashton
Journal:  Can J Infect Dis       Date:  2002-11

7.  Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19).

Authors:  Dennis K S Law; Manon Lorange; Louise Ringuette; Réjean Dion; Michel Giguère; Averil M Henderson; Jan Stoltz; Wendell D Zollinger; Philippe De Wals; Raymond S W Tsang
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

8.  Advice for Consideration of Quadrivalent (A, C, Y, W135) Meningococcal Conjugate Vaccine, for use by Provinces and Territories.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2010-01-26

Review 9.  The changing epidemiology of meningococcal disease in North America 1945-2010.

Authors:  Carmen Baccarini; Andrew Ternouth; Heather Wieffer; Andrew Vyse
Journal:  Hum Vaccin Immunother       Date:  2012-10-29       Impact factor: 3.452

10.  Enhanced surveillance of invasive meningococcal disease in Canada, 2006-2011.

Authors:  Y A Li; R Tsang; S Desai; H Deehan
Journal:  Can Commun Dis Rep       Date:  2014-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.